Z-2286-2018 Class II Terminated
FDA device recall Z-2286-2018 was initiated by Horiba Instruments, Inc Dba Horiba Medical on Apr 26, 2018 and is designated Class II. Reason for recall: When the ABX Pentra Micro ALBUMIN 2 CP (ALBT2) Reagent 2 is sampled and dispensed immediately after an ABX Pentra Creatinine 120 CP (CREA3) Reagent 2 dispense, the final result of the microalbumin may… The recall status is terminated (terminated Sep 26, 2019). Affected quantity: 686 devices (233 devices US, 453 devices OUS).
Recall details
- Product Type
- Devices
- Report Date
- Jul 4, 2018
- Initiation Date
- Apr 26, 2018
- Termination Date
- Sep 26, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 686 devices (233 devices US, 453 devices OUS)
Product description
Reason for recall
Distribution pattern
Worldwide Distribution: US (nationwide) and to countries of: Bulgaria, Burma, Cameroon, Djibouti, France, Gabon, Germany, Italy, Lebanon, Mali, Mauritania, Poland, Portugal, Romania, Saudi Arabia, South Africa and Thailand.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2286-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026